Molecular insight into arrhythmogenic cardiomyopathy caused by DSG2 mutations
Mutant desmoglein 2 (DSG2) is the second most common pathogenic gene in arrhythmogenic cardiomyopathy (ACM), accounting for approximately 10% of ACM cases. In addition to common clinical and pathological features, ACM caused by mutant DSG2 has specific characteristics, manifesting as left ventricle...
Main Authors: | Baowei Zhang, Yizhang Wu, Xingbo Yang, Yaozu Xiang, Bing Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-11-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223012465 |
Similar Items
-
Reactivation of PPARα alleviates myocardial lipid accumulation and cardiac dysfunction by improving fatty acid β-oxidation in Dsg2-deficient arrhythmogenic cardiomyopathy
by: Yubi Lin, et al.
Published: (2023-01-01) -
Activation of PPARα Ameliorates Cardiac Fibrosis in Dsg2-Deficient Arrhythmogenic Cardiomyopathy
by: Zirui Qiu, et al.
Published: (2022-10-01) -
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Probably Caused by DSG2 p.Val149Ile Mutation as Genetic Background When Carrying with Heterozygous PRRT2 p.Arg217ProfsTer8 Mutation: A Case Report
by: Huang R, et al.
Published: (2021-05-01) -
Novel gene mutation identified in a patient with arrhythmogenic ventricular cardiomyopathy
by: Jeremy W. Docekal, MD, et al.
Published: (2017-10-01) -
Arrhythmogenic Cardiomyopathy: Molecular Insights for Improved Therapeutic Design
by: Tyler L. Stevens, et al.
Published: (2020-05-01)